Actively Recruiting

Phase 1
Age: 18Years - 45Years
FEMALE
Healthy Volunteers
NCT06379971

Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development

Led by University of Colorado, Denver · Updated on 2025-02-03

140

Participants Needed

1

Research Sites

231 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to determine if providing a nutritional supplement, phosphatidylcholine, to pregnant women who have used cannabis products during the current pregnancy improves the offspring\'s brain-related development during the first 3 months. Participating pregnant women will receive either phosphatidylcholine or a placebo from approximately 16 weeks gestation through birth. The primary outcomes are the child\'s brain responses to sound at 4 weeks corrected age and infant behaviors at 3 months corrected age as reported by the primary caregiver. Secondary outcomes include motor, socio-emotional, language and cognitive development.

CONDITIONS

Official Title

Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development

Who Can Participate

Age: 18Years - 45Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women who report cannabis use during current pregnancy
Not Eligible

You will not qualify if you...

  • Pregnancies with fetal anomalies like neural tube defects, chromosomal abnormalities, or multiple gestations
  • Women with major existing medical illnesses
  • Women with a previous fetal death
  • Current chronic infections including HIV
  • Personal or first-degree family history of trimethylaminuria or homocystinuria
  • Primary language other than English or Spanish
  • Evidence of noncompliance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UC Health

Aurora, Colorado, United States, 80045

Actively Recruiting

Loading map...

Research Team

M

M. Camille Hoffman, MD

CONTACT

S

Sharon Hunter, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here